XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,900,286 | -56.2% | 143,451 | -50.6% | 0.06% | -57.1% |
| Q2 2023 | $11,180,400 | -25.6% | 290,400 | -30.9% | 0.13% | -35.1% |
| Q1 2023 | $15,032,838 | +27.7% | 420,029 | +40.7% | 0.20% | +30.6% |
| Q4 2022 | $11,767,489 | -19.4% | 298,440 | -26.2% | 0.16% | -23.0% |
| Q3 2022 | $14,597,000 | +109.6% | 404,359 | +76.6% | 0.20% | +90.7% |
| Q2 2022 | $6,964,000 | +127.9% | 228,928 | +14.5% | 0.11% | +114.0% |
| Q3 2021 | $3,056,000 | – | 199,984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |